Skip to main content
Log in

Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

The aim of this study was to assess the incidence, clinical predictors, and outcome of patients developing contrast medium induced nephropathy (CIN) after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS).

Background

CIN is associated with significant higher morbidity and mortality after coronary intervention. Recently it was shown, that patients undergoing percutaneous coronary intervention for acute myocardial infarction have a significant higher risk of developing CIN. Non-ST-elevating myocardial infarction (NSTEMI) patients (pts) might be at an even higher risk developing CIN than patients with ST-elevating myocardial infarction (STEMI), because of presenting older and more often with diabetes.

Methods

In 392 consecutive ACS patients developing myocardial infarction and therefore undergoing emergent coronary angiography between October 2004 and March 2007, we measured serum creatinine concentration (Cr) at baseline and each day of the following 3 days. Contrast medium induced nephropathy was defined as an increase in Cr > 0.5 mg/dl. ACS was defined according to the guidelines of the German Society of Cardiology.

Results

Overall, 392 pts were included: 203 (51.8%) with STEMI and 189 (48.2%) with NSTEMI. Patients with STEMI developed more often a cardiogenic shock (18 vs. 6%; P < 0.001) whereas patients with NSTEMI were older (67 vs. 61 years; P < 0.001) and presenting with a higher co-morbidity. Forty-five (11.5%) pts developed CIN; 22 (10.8%) in the STEMI group and 23(12.2%) in the NSTEMI group (P = 0.75). Patients developing CIN presented a more complicated clinical course and a significantly longer hospital stay (14 vs. 10 days; P < 0.001). The mortality rate was also significantly higher (16 vs. 6%; P < 0.05).

Conclusion

This prospective study showed no differences in the incidence of developing CIN in patients undergoing PCI for STEMI or NSTEMI, but the predisposing factors, however, differed significantly. Although STEMI patients needed significantly more contrast medium for revascularisation, they did not develop CIN more often. CIN was associated with higher in-hospital complication rate and mortality. Thus, better preventive strategies according to the different predisposing factors leading to CIN are needed to reduce morbidity and mortality, especially in high risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

ACS:

Acute coronary syndrome

AMI:

Acute myocardial infarction

CAD:

Coronary artery disease

CCU:

Coronary care unit

CIN:

Contrast induced nephropathy

Cr:

Creatinine clearance

PCI:

Percutaneous coronary intervention

References

  1. Arend LJ, Bakris GL et al (1987) Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 110(4):406–411

    CAS  PubMed  Google Scholar 

  2. Bauer T, Hoffmann R et al (2009) Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice. Clin Res Cardiol 98(3):171–178

    Article  PubMed  Google Scholar 

  3. Best PJ, Lennon R et al (2002) The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39(7):1113–1119

    Article  PubMed  Google Scholar 

  4. Bode C, Zirlik A (2007) STEMI and NSTEMI: the dangerous brothers. Eur Heart J 28(12):1403–1404

    Article  PubMed  Google Scholar 

  5. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41

    Article  CAS  PubMed  Google Scholar 

  6. D’Elia JA, Gleason RE et al (1982) Nephrotoxicity from angiographic contrast material. A prospective study. Am J Med 72(5):719–725

    Article  PubMed  Google Scholar 

  7. Debrunner M, Schuiki E et al (2008) Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 97(5):298–305

    Article  CAS  PubMed  Google Scholar 

  8. Deray G, Baumelou B et al (1991) Renal vasoconstriction after low and high osmolar contrast agents in ischemic and non ischemic canine kidney. Clin Nephrol 36(2):93–96

    CAS  PubMed  Google Scholar 

  9. Elsasser A, Nef H et al (2005) Clopidogrel in acute coronary syndrome: when, how much, how long? Z Kardiol 94(6):377–382

    Article  CAS  PubMed  Google Scholar 

  10. Gruberg L, Mintz GS et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36(5):1542–1548

    Article  CAS  PubMed  Google Scholar 

  11. Hamm CW (2004) Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations. Z Kardiol 93(1):72–90

    Article  CAS  PubMed  Google Scholar 

  12. Hamm CW (2004) Guidelines: acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation. Z Kardiol 93(4):324–341

    Article  CAS  PubMed  Google Scholar 

  13. Humes HD, Hunt DA et al (1987) Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 252(2 Pt 2):F246–F255

    CAS  PubMed  Google Scholar 

  14. Iijima R, Ndrepepa G et al (2008) Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment. Clin Res Cardiol 97(3):160–168

    Article  CAS  PubMed  Google Scholar 

  15. Keeley EC, Boura JA et al (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361(9351):13–20

    Article  PubMed  Google Scholar 

  16. Khattab AA, Abdel-Wahab M et al (2008) Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol 97(1):32–38

    Article  CAS  PubMed  Google Scholar 

  17. Lameire N, Van Biesen W et al (2005) Acute renal failure. Lancet 365(9457):417–430

    CAS  PubMed  Google Scholar 

  18. Marenzi G, Lauri G et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44(9):1780–1785

    Article  PubMed  Google Scholar 

  19. McCullough PA, Adam A et al (2006) Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98(6A):5K–13K

    Article  CAS  PubMed  Google Scholar 

  20. Meyborg P, Abdel-Wahab M et al (2007) Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction. Clin Res Cardiol 96(2):94–102

    Article  CAS  PubMed  Google Scholar 

  21. Montalescot G, Dallongeville J et al (2007) STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 28(12):1409–1417

    Article  PubMed  Google Scholar 

  22. Parfrey PS, Griffiths SM et al (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320(3):143–149

    Article  CAS  PubMed  Google Scholar 

  23. Pohlen M, Bunzemeier H et al (2008) Risk predictors for adverse outcomes after percutaneous coronary interventions and their related costs. Clin Res Cardiol 97(7):441–448

    Article  PubMed  Google Scholar 

  24. Prechelt L, Lanzer P (2007) On understanding the power of judgement in percutaneous coronary intervention. Clin Res Cardiol 96(4):199–203

    Article  PubMed  Google Scholar 

  25. Recio-Mayoral A, Chaparro M et al (2007) The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol 49(12):1283–1288

    Article  CAS  PubMed  Google Scholar 

  26. Reinecke H, Fobker M et al (2007) A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial. Clin Res Cardiol 96(3):130–139

    Article  CAS  PubMed  Google Scholar 

  27. Rihal CS, Textor SC et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105(19):2259–2264

    Article  PubMed  Google Scholar 

  28. Sadeghi HM, Stone GW et al (2003) Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108(22):2769–2775

    Article  PubMed  Google Scholar 

  29. Scheller B (2007) How to protect from contrast media-induced nephropathy? Clin Res Cardiol 96(3):125–129

    Article  CAS  PubMed  Google Scholar 

  30. Shlipak MG, Heidenreich PA et al (2002) Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137(7):555–562

    PubMed  Google Scholar 

  31. Tepel M (2006) Preventing nephropathy induced by contrast medium. N Engl J Med 354(17):1853–1855 (author reply 1853–5)

    Article  PubMed  Google Scholar 

  32. Van de Werf F, Ardissino D et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 24(1):28–66

    Article  PubMed  Google Scholar 

  33. Walsh CR, O’Donnell CJ et al (2002) Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 144(6):1003–1011

    Article  CAS  PubMed  Google Scholar 

  34. Weinrauch LA, Healy RW et al (1977) Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 86(1):56–59

    CAS  PubMed  Google Scholar 

  35. Wilansky S, Moreno CA et al (2007) Complications of myocardial infarction. Crit Care Med 35(8 suppl):S348–S354

    Article  PubMed  Google Scholar 

  36. Wright RS, Reeder GS et al (2002) Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137(7):563–570

    PubMed  Google Scholar 

  37. Yusuf S, Zhao F et al (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494–502

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ingo Wickenbrock.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wickenbrock, I., Perings, C., Maagh, P. et al. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 98, 765–772 (2009). https://doi.org/10.1007/s00392-009-0058-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-009-0058-5

Keywords

Navigation